- Report
- August 2025
- 192 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP
- Report
- August 2025
- 196 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP
- Report
- August 2025
- 195 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP
- Report
- August 2025
- 180 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP
- Report
- November 2025
- 185 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- August 2025
- 188 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- June 2025
- 182 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- May 2025
- 182 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- April 2025
- 185 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- April 2025
- 184 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- March 2025
- 184 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- February 2025
- 185 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- February 2025
- 185 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- January 2025
- 185 Pages
Global
From €3967EUR$4,500USD£3,460GBP
- Report
- November 2025
- 200 Pages
Global
From €5607EUR$6,360USD£4,890GBP
€7009EUR$7,950USD£6,112GBP
- Drug Pipelines
- April 2025
- 450 Pages
Global
From €3527EUR$4,000USD£3,075GBP
€4408EUR$5,000USD£3,844GBP
- Report
- December 2025
- 382 Pages
Global
From €5158EUR$5,850USD£4,498GBP
- Report
- December 2025
- 274 Pages
Global
From €5158EUR$5,850USD£4,498GBP
- Report
- December 2025
- 278 Pages
Global
From €5158EUR$5,850USD£4,498GBP
- Report
- December 2025
- 274 Pages
Global
From €5158EUR$5,850USD£4,498GBP

The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more